Sanofi SA's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Assets" stands at 7.16 percent as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Return On Assets" stands at 7.16 Percent. This represents a decrease of -2.40 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.1246 percentage points compared to the value the year prior.
The 1 year change in percentage points is 0.1246.
The 3 year change in percentage points is -3.40.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Return On Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Assets | 280,205,508,085.11 |